Skip to main content
Signal8

Boyd Taylor

SEC insider (Form 3/4/5 filer). CIK 0002090172. Chief Business Officer at Avalo Therapeutics, Inc. (AVTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in WAYNE, PA.

Companies Boyd Taylor has filed insider reports for

  • Avalo Therapeutics, Inc. (AVTX): Officer, Chief Business Officer
Boyd Taylor profile photo

Boyd Taylor

CIK: 0002090172

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Avalo Therapeutics, Inc. logo
AVTX

Avalo Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Avalo Therapeutics, Inc. logo
    AVTX

    Avalo Therapeutics, Inc.

    Feb 26, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    95K shares-
  • Avalo Therapeutics, Inc. logo
    AVTX

    Avalo Therapeutics, Inc.

    Oct 1, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    275K shares-

1-2 of 2